| Current and future burden of breast cancer: Global statistics for 2020 and 2040 M Arnold, E Morgan, H Rumgay, A Mafra, D Singh, M Laversanne, ... The Breast 66, 15-23, 2022 | 966 | 2022 |
| Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study M Arnold, MJ Rutherford, A Bardot, J Ferlay, TML Andersson, ... The Lancet Oncology 20 (11), 1493-1505, 2019 | 871 | 2019 |
| Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN E Morgan, M Arnold, A Gini, V Lorenzoni, CJ Cabasag, M Laversanne, ... Gut 72 (2), 338-344, 2023 | 433 | 2023 |
| Changes in colorectal cancer incidence in seven high-income countries: a population-based study M Araghi, I Soerjomataram, A Bardot, J Ferlay, CJ Cabasag, DS Morrison, ... The Lancet Gastroenterology & Hepatology 4 (7), 511-518, 2019 | 363 | 2019 |
| The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020 E Morgan, I Soerjomataram, H Rumgay, HG Coleman, AP Thrift, J Vignat, ... Gastroenterology 163 (3), 649-658. e2, 2022 | 284 | 2022 |
| The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study E Morgan, M Arnold, MC Camargo, A Gini, AT Kunzmann, T Matsuda, ... eClinicalMedicine 47, 101404, 2022 | 263 | 2022 |
| Trends in incidence of thick, thin and in situ melanoma in Europe L Sacchetto, R Zanetti, H Comber, C Bouchardy, DH Brewster, ... European journal of cancer 92, 108-118, 2018 | 212 | 2018 |
| Epidemiology of basal and cutaneous squamous cell carcinoma in the UK 2013–15: a cohort study ZC Venables, T Nijsten, KF Wong, P Autier, J Broggio, A Deas, ... British Journal of Dermatology 181 (3), 474-482, 2019 | 132 | 2019 |
| Colon and rectal cancer survival in seven high-income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project) M Araghi, M Arnold, MJ Rutherford, MG Guren, CJ Cabasag, A Bardot, ... Gut 70 (1), 114-126, 2021 | 94 | 2021 |
| Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: a systematic review of population-based cohorts E Morgan, CR Cardwell, CJ Black, DR McCance, CC Patterson Acta diabetologica 52, 801-807, 2015 | 85 | 2015 |
| Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies E Morgan, SR Halliday, GR Campbell, CR Cardwell, CC Patterson Diabetologia 59, 237-243, 2016 | 76 | 2016 |
| Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015 TSE Genus, C Bouvier, KF Wong, R Srirajaskanthan, BA Rous, DC Talbot, ... British journal of cancer 121 (11), 966-972, 2019 | 66 | 2019 |
| International trends in oesophageal cancer survival by histological subtype between 1995 and 2014 E Morgan, I Soerjomataram, AT Gavin, MJ Rutherford, P Gatenby, ... Gut, 2020 | 60 | 2020 |
| Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989‐2012: A population‐based cohort study E Morgan, CR Black, N Abid, CR Cardwell, DR McCance, CC Patterson Pediatric diabetes 19 (1), 166-170, 2018 | 40 | 2018 |
| Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study CJ Cabasag, J Butler, M Arnold, M Rutherford, A Bardot, J Ferlay, ... Gynecologic oncology 157 (1), 234-244, 2020 | 36 | 2020 |
| International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study) M Arnold, E Morgan, A Bardot, MJ Rutherford, J Ferlay, A Little, B Møller, ... Gut 71 (8), 1532-1543, 2022 | 30 | 2022 |
| A population-level investigation of cancer clinical trials participation in a UK region CB Donnelly, AC Wotherspoon, M Morris, RH Wilson, JJ Chen, ... European Journal of Cancer Prevention 26, S229-S235, 2017 | 18 | 2017 |
| The psychological impact of prostate biopsy: Prevalence and predictors of procedure‐related distress L Sharp, E Morgan, FJ Drummond, A Gavin Psycho‐oncology 27 (2), 500-507, 2018 | 16 | 2018 |
| Global variations in lung cancer incidence by histological subtype in 2020: a population-based study Y Zhang, S Vaccarella, E Morgan, M Li, J Etxeberria, E Chokunonga, ... The Lancet Oncology 24 (11), 1206-1218, 2023 | 15 | 2023 |
| The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non‐small cell lung cancer (ICBP SurvMark‐2 project) E Morgan, M Arnold, MJ Rutherford, A Bardot, J Ferlay, P De, G Engholm, ... International Journal of Cancer 149 (5), 1013-1020, 2021 | 11 | 2021 |
Citadel J CabasagIQVIAVerified email at iqvia.com
